OR WAIT null SECS
July 02, 2021
Five therapeutic candidates for the treatment of COVID-19 are identified as promising by the European Commission.
June 30, 2021
Chalmers University researchers have developed a method to label and track mRNA molecules.
CDMO Yposkesi will increase its current gene therapy vector capacity through French government’s “Plan de Relance” scheme.
CatSci has opened its new Dagenham, UK-based laboratory, which is dedicated to analytical excellence.
The Cell and Gene Therapy Catapult will establish offices and laboratories in Edinburgh, Scotland.
Evonik has released an innovative green technology that can enable the large-scale synthesis of APIs in water.
Pharmapack Europe event organizers have revealed increased levels of innovation in drug delivery across the industry, substantiated by the level of regulatory approvals.
June 29, 2021
The Council of Europe has appointed Petra Dörr, PhD, as the future director of the European Directorate for the Quality of Medicines and Healthcare (EDQM).
EMA's CHMP has adopted a positive opinion recommending the approval of UCB’s bimekizumab (Bimzelx) for the treatment of plaque psoriasis.
Otsuka Pharmaceuticals Europe has filed an initial marketing authorization application to the European Medicines Agency for voclosporin.